Document is current
Any future updates will be listed below
-
Authors
Rivera, Carlos
Verbel-Vergara, Daniel
Arancibia, Duxan
Lappala, Anna
González, Marcela
Guzmán, Fabián
Merello, Gianluca
Lee, Jeannie T.
Andrés, María Estela http://orcid.org/0000-0002-2078-2770
-
Funding
Funding for this research was provided by:
Fondecyt (1150200, 1191152)
National Institutes of Health (R01-HD097665)
ANID (21161044, 21212317, 21150971)
- License Information
-
More Information
Article History
Received: 20 October 2021
Accepted: 31 October 2021
First Online: 24 November 2021
Declarations
:
: Not applicable.
: Not applicable.
: J.T.L. is a co-founder of Translate Bio and Fulcrum Therapeutics, and also serves as Advisor to Skyhawk Therapeutics.
